Merck Nobivac Canine 1-Cv Vaccine 25 x 1 mL Dose

Merck Nobivac Canine 1-Cv Vaccine 25 x 1 mL Dose

Designed to enhance the immune response and offer protection against canine coronavirus.

• The virus has been inactivated and combined with an adjuvant designed to enhance the immune response
• Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection

• Inject initial 1 mL dose subcutaneously or intramuscularly
• The initial dose may be given at 6 weeks of age
• A second, required dose is given 2-4 weeks later
• Annual revaccination with one dose is recommended
• Use entire contents immediately
• Available in a 25 x 1 mL dose presentation